NCT04935320View on ClinicalTrials.gov

Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

October 29, 2021

Study Completion Date

October 29, 2021

Conditions
Healthy Subjects
Interventions
DRUG

HTL0016878.HCl Solution 10 mg

Oral solution fasted

DRUG

HTL0016878.Citrate Capsule 10 mg

Oral capsule fed or fasted

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research Ltd (HMR), London

All Listed Sponsors
lead

Nxera Pharma UK Limited

INDUSTRY

NCT04935320 - Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution | Biotech Hunter | Biotech Hunter